Insights into the regulatory role of RNA methylation modifications in glioma
Shengrong Long,Yu Yan,Hongyu Xu,Lesheng Wang,Jiazhi Jiang,Ziyue Xu,Runming Liu,Qiangqiang Zhou,Xiaopeng Huang,Jincao Chen,Zhiqiang Li,Wei Wei,Xiang Li
DOI: https://doi.org/10.1186/s12967-023-04653-y
IF: 8.44
2023-01-01
Journal of Translational Medicine
Abstract:Epitranscriptomic abnormalities, which are highly prevalent in primary central nervous system malignancies, have been identified as crucial contributors to the development and progression of gliomas. RNA epitranscriptomic modifications, particularly the reversible modification methylation, have been observed throughout the RNA cycle. Epitranscriptomic modifications, which regulate RNA transcription and translation, have profound biological implications. These modifications are associated with the development of several cancer types. Notably, three main protein types—writers, erasers, and readers, in conjunction with other related proteins, mediate these epitranscriptomic changes. This review primarily focuses on the role of recently identified RNA methylation modifications in gliomas, such as N6-methyladenosine (m6A), 5-methylcytosine (m5C), N7-methylguanosine (m7G), and N1-methyladenosine (m1A). We delved into their corresponding writers, erasers, readers, and related binding proteins to propose new approaches and prognostic indicators for patients with glioma.